II
RGEN icon

IFM Investors’s Repligen RGEN Stock Holding History

IFM Investors’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,747
Closed -$1.35M – 691
2024
Q2 		$1.35M Sell
10,747
-446
-4% -$69.9K 0.01% 575
2024
Q1 		$2.06M Buy
11,193
+553
+5% +$105K 0.02% 521
2023
Q4 		$1.91M Hold
10,640
– – 0.02% 503
2023
Q3 		$1.69M Sell
10,640
-166
-2% -$27.1K 0.02% 540
2023
Q2 		$1.53M Buy
10,806
+199
+2% +$31.9K 0.02% 556
2023
Q1 		$1.79M Buy
10,607
+108
+1% +$19.3K 0.03% 511
2022
Q4 		$1.78M Buy
+10,499
New +$1.9M 0.03% 499

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

IFM Investors's RGEN Position: Q3 2024 in Review

IFM Investors sold out of Repligen (RGEN) in Q3 2024, closing a stake of 10,747 shares — an estimated $1.35M sold.

IFM Investors first reported a position in RGEN in Q4 2022 and held it in 7 quarters. The position peaked at $2.06M in Q1 2024. 444 funds tracked by Wall St. Rank hold RGEN as of Q3 2024.

  • IFM Investors reported no remaining Repligen position as of Q3 2024 after selling out during the quarter.
  • IFM Investors sold 10,747 Repligen shares in Q3 2024, an estimated $1.35M.
  • IFM Investors first reported a position in Repligen in Q4 2022 and held it in 7 quarters.
  • IFM Investors's Repligen position peaked at $2.06M in Q1 2024.
  • 444 funds tracked by Wall St. Rank held Repligen as of Q3 2024.

Based on IFM Investors's 13F filing for Q3 2024, filed 23 Oct 2024.